UM
HRMY icon

UniSuper Management’s Harmony Biosciences HRMY Stock Holding History

UniSuper Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,598
Closed -$350K – 817
2024
Q2 		$350K Hold
11,598
– – ﹤0.01% 878
2024
Q1 		$389K Buy
+11,598
New +$372K ﹤0.01% 824

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UniSuper Management's HRMY Position: Q3 2024 in Review

UniSuper Management sold out of Harmony Biosciences (HRMY) in Q3 2024, closing a stake of 11,598 shares — an estimated $350K sold.

UniSuper Management first reported a position in HRMY in Q1 2024 and held it in 2 quarters. The position peaked at $389K in Q1 2024. 233 funds tracked by Wall St. Rank hold HRMY as of Q3 2024.

  • UniSuper Management reported no remaining Harmony Biosciences position as of Q3 2024 after selling out during the quarter.
  • UniSuper Management sold 11,598 Harmony Biosciences shares in Q3 2024, an estimated $350K.
  • UniSuper Management first reported a position in Harmony Biosciences in Q1 2024 and held it in 2 quarters.
  • UniSuper Management's Harmony Biosciences position peaked at $389K in Q1 2024.
  • 233 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2024.

Based on UniSuper Management's 13F filing for Q3 2024, filed 14 Nov 2024.